Literature DB >> 11886334

The dilemma of treating hypopharyngeal carcinoma: more or less: Hayes Martin Lecture.

William I Wei1.   

Abstract

The optimal therapy for hypopharyngeal carcinoma depends on its staging. For early-stage disease, radiotherapy and surgery achieve similar results. Radical surgery followed by radiotherapy is applicable in the management of patients with advanced-stage disease. Chemoradiation aiming to preserve the larynx can only be performed for selected patients and in well-equipped institutions. Thorough understanding of pathological behavior of hypopharyngeal carcinoma, its submucosal tumor extension, and its high propensity to metastasize to cervical lymph nodes allows head and neck surgeons to choose optimal surgical treatment. Lymph node status determines the type of neck dissection required while location and size of the primary tumor determine the extent of resection and choice of reconstruction procedure. Adequate tumor extirpation with less extensive and invasive procedures preserving unaffected normal tissue contribute to more tumor control and less morbidity.

Entities:  

Mesh:

Year:  2002        PMID: 11886334     DOI: 10.1001/archotol.128.3.229

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

1.  Stromal interaction molecule 1 (STIM1) silencing inhibits tumor growth and promotes cell cycle arrest and apoptosis in hypopharyngeal carcinoma.

Authors:  Yuanhao Sun; Xiaobo Cui; Jun Wang; Shuai Wu; Yunfei Bai; Yaping Wang; Boqian Wang; Jugao Fang
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

2.  Role of Total Laryngopharyngoesophagectomy with Gastric Pull Up in the Management of Locally Advanced Hypopharyngeal Cancers.

Authors:  K Devaraja; Kailesh Pujary; Balakrishnan Ramaswamy; Dipak Ranjan Nayak; Kallya Rajgopal Shenoy; Prerit Rao
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-29

Review 3.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 4.  Surgical errors and risks - the head and neck cancer patient.

Authors:  Ulrich Harréus
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

5.  The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.

Authors:  Pichit Sittitrai; Donyarat Reunmarkkaew; Saisaward Chaiyasate
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-10-16

6.  The impact of paratracheal lymph node metastasis in squamous cell carcinoma of the hypopharynx.

Authors:  Young-Hoon Joo; Dong-Il Sun; Kwang-Jae Cho; Jung-Hae Cho; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-01       Impact factor: 2.503

7.  Epidemiological assessment and therapeutic response in hypopharyngeal cancer.

Authors:  Ali Amar; Otávio Alberto Curioni; Diógenes Lopes de Paiva; Abrão Rapoport; Rogério Aparecido Dedivitis; Claudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Braz J Otorhinolaryngol       Date:  2013-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.